Psoriasis: all 1,928 studies

Page 6 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.

• A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque PsoriasisCompletedNCT02445807Phase 3Results posted
• Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type PsoriasisCompletedNCT02432040Phase 2Results posted
• A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.CompletedNCT02425826Phase 4Results posted
• A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical StudyCompletedNCT02413229Phase 2Results posted
• Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque PsoriasisCompletedNCT02412644Phase 4Results posted
• Plaque Psoriasis Efficacy and Safety With SecukinumabCompletedNCT02409667Phase 3Results posted
• An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of PsoriasisCompletedNCT02407041Phase 2Results posted
• Apremilast in Palmo-Plantar PsoriasisCompletedNCT02400749Phase 4Results posted
• Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque PsoriasisCompletedNCT02387853Phase 2Results posted
• A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe PsoriasisCompletedNCT02387801Phase 3Results posted
• A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)CompletedNCT02368210Phase 3Results posted
• A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque PsoriasisCompletedNCT02367911Phase 3Results posted
• Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional BiomarkersCompletedNCT02362789Phase 3Results posted
• Collaborative Connected Health (CCH) for PCORICompletedNCT02358135Not applicableResults posted
• Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)CompletedNCT02346240Phase 3Results posted
• Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque PsoriasisCompletedNCT02340169Phase 4Results posted
• An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)CompletedNCT02326298Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)CompletedNCT02326272Phase 3Results posted
• An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type PsoriasisCompletedNCT02325219Phase 3Results posted
• Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line TherapyCompletedNCT02317627Phase 2Results posted
• A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect InvestigationCompletedNCT02310750Phase 1Results posted
• Patient Insights Following Use of LEO 90100 Aerosol Foam and Daivobet® Gel in Subjects With Psoriasis VulgarisCompletedNCT02310646Phase 3Results posted
• Excimer Laser Phototherapy Outcomes in the Treatment of PsoriasisTerminatedNCT02294981Not applicableResults posted
• Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque PsoriasisCompletedNCT02274792Phase 4Results posted
• Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp PsoriasisCompletedNCT02267135Phase 3Results posted
• A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and RetreatmentCompletedNCT02207244Phase 3Results posted
• A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type PsoriasisCompletedNCT02207231Phase 3Results posted
• Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT02203851Phase 2Results posted
• A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to UstekinumabCompletedNCT02203032Phase 3Results posted
• Study to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisTerminatedNCT02201524Phase 2Results posted
• Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR StudyCompletedNCT02196701Phase 3Results posted
• A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque PsoriasisCompletedNCT02195349Phase 1Results posted
• A 12 Day Study To Evaluate A Topical Drug To Treat Plaque PsoriasisCompletedNCT02193815Phase 1Results posted
• Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in PsoriasisCompletedNCT02192164Results posted
• Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)CompletedNCT02187172Phase 4Results posted
• Plaque Psoriasis Study in Pediatric SubjectsCompletedNCT02186665Phase 4Results posted
• Addition of Excimer Laser to Treatment With Acitretin Tablets for Psoriasis of the Palms and SolesTerminatedNCT02181790Phase 4Results posted
• A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of BrodalumabCompletedNCT02173392Phase 1Results posted
• A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type PsoriasisCompletedNCT02173301Phase 2Results posted
• 308nm Excimer Laser for Treatment of Fingernail PsoriasisCompletedNCT02168933Not applicableResults posted
• Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis SubjectsCompletedNCT02156466Phase 1Results posted
• Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)CompletedNCT02134210Phase 3Results posted
• LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis VulgarisCompletedNCT02132936Phase 3Results posted
• DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT02131324Phase 2Results posted
• Efficacy and Safety of Namilumab (MT203) for Plaque PsoriasisCompletedNCT02129777Phase 2Results posted
• Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque PsoriasisCompletedNCT02125279Phase 4Results posted
• Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasisCompletedNCT02107482Not applicableResults posted
• A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis VulgarisCompletedNCT02106195Phase 2Results posted
• Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate CreamCompletedNCT02075632Phase 2Results posted
• Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type PsoriasisCompletedNCT02074982Phase 3Results posted
• DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT02070965Phase 2Results posted
• BI 655066 Dose Ranging in Psoriasis, Active Comparator UstekinumabCompletedNCT02054481Phase 2Results posted
• Safety and Efficacy of IDP 118 in the Treatment of Plaque PsoriasisCompletedNCT02045277Phase 2Results posted
• An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent SubjectsCompletedNCT02038569Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail PsoriasisCompletedNCT02016482Phase 3Results posted
• Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and HumiraCompletedNCT02016105Phase 3Results posted
• Palmoplantar Pustular Psoriasis Efficacy and Safety With SecukinumabCompletedNCT02008890Phase 3Results posted
• Blue Light for Treating Psoriasis VulgarisCompletedNCT02004847Not applicableResults posted
• Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis VulgarisCompletedNCT01999868Phase 2Results posted
• Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.CompletedNCT01991197Phase 2Results posted
• Etanercept and Vascular Function in PsoriasisCompletedNCT01989689Phase 2Results posted
• Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type PsoriasisCompletedNCT01988103Phase 2Results posted
• Effects of Subcutaneous Hyaluronidase Administration on Psoriatic PlaquesCompletedNCT01987609Phase 2Results posted
• The Immunological Basis for Treatment Resistance to Anti-TNF TreatmentsCompletedNCT01971346Phase 4Results posted
• Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque PsoriasisCompletedNCT01970488Phase 3Results posted
• A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate PsoriasisCompletedNCT01967069Phase 3Results posted
• Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.CompletedNCT01961609Phase 3Results posted
• Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)CompletedNCT01952015Phase 3Results posted
• A Safety Study of Mirikizumab (LY3074828)CompletedNCT01947933Phase 1Results posted
• A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate PsoriasisCompletedNCT01947491Phase 3Results posted
• Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis SubjectsCompletedNCT01937260Phase 1Results posted
• Photocil (Topical) for the Treatment of Psoriasis VulgarisCompletedNCT01916629Not applicableResults posted
• A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT01899729Phase 2Results posted
• Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%CompletedNCT01893567Phase 4Results posted
• Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and EnbrelCompletedNCT01891864Phase 3Results posted
• A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)CompletedNCT01882647Phase 3Results posted
• Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With EtanerceptCompletedNCT01875991Phase 4Results posted
• A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)CompletedNCT01871402Phase 3Results posted
• Vascular Inflammation in Psoriasis - Extension StudyCompletedNCT01866592Phase 4Results posted
• LEO 90100 Compared to Vehicle in Subjects With Psoriasis VulgarisCompletedNCT01866163Phase 3Results posted
• Tofacitinib Ointment For Chronic Plaque PsoriasisCompletedNCT01831466Phase 2Results posted
• Paired Psoriasis Lesion, Comparative, Study to Evaluate MOL4239 in PsoriasisCompletedNCT01826201Phase 2Results posted
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque PsoriasisCompletedNCT01815424Phase 3Results posted
• Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail PsoriasisCompletedNCT01807520Phase 3Results posted
• Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar PsoriasisCompletedNCT01806597Phase 3Results posted
• Using an Internet Study to Improve Adherence for Psoriasis PatientsCompletedNCT01802580Early Phase 1Results posted
• Anakinra for Inflammatory Pustular Skin DiseasesCompletedNCT01794117Phase 2Results posted
• A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque PsoriasisCompletedNCT01782664Phase 2Results posted
• Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT01777191Phase 3Results posted
• Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeCompletedNCT01768858Results posted
• The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis VulgarisCompletedNCT01768013Phase 1/2Results posted
• PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque PsoriasisCompletedNCT01766440Phase 4Results posted
• A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic TherapyCompletedNCT01761019Phase 4Results posted
• Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque PsoriasisCompletedNCT01745133Phase 4Results posted
• Multiple Dose Escalation Study In Medically Stable Subjects With PsoriasisCompletedNCT01736696Phase 1Results posted
• A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)CompletedNCT01722331Phase 3Results posted
• Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque PsoriasisCompletedNCT01714544Phase 4Results posted
• Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque PsoriasisCompletedNCT01710046Phase 2Results posted
• Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis SubjectsTerminatedNCT01708629Phase 3Results posted
• P3 Study Brodalumab in Treatment of Moderate to Severe Plaque PsoriasisTerminatedNCT01708603Phase 3Results posted

← Psoriasis overview